Kara Rosania, MS

The Value of Genetic Testing for Familial Hypercholesterolemia

12/21/2018

Recent guidance from clinical experts have urged the wider use of genetic testing for familial hypercholesterolemia, given the benefits of early intervention in these patients and the availability of targeted treatments. However, payers must...

Recent guidance from clinical...

12/21/2018

First Report Managed Care

Are Payers Reconsidering PCSK9 Inhibitors?

12/21/2018

Kara Rosania , MS;

Payer acceptance of the cholesterol-lowering PCSK9 inhibitors Repatha and Praluent has been limited, due to the high costs of these medications. However, steps by the drugs’ manufacturers, as well as new cardiovascular outcomes data...

Payer acceptance of the...

12/21/2018

First Report Managed Care

LTC Bulletin Board

Antibiotics Overused in Nursing Homes, Study Shows

07/20/2015

Kara Rosania , MS;

A new study suggests antibiotics are likely being overused in some nursing homes and reports a link between this practice and a higher risk of adverse outcomes for all residents in these facilities.

A new study suggests antibiotics...

07/20/2015

Annals of Long-Term Care

NRS Approved Features

Helping Patients to Recognize Facial Redness

10/18/2019

Kara Rosania , MS;

Persistent facial erythema can affect quality of life for patients with rosacea. A new booklet with a handy redness register can help patients gauge their facial redness before and after a flare-up.

Persistent facial erythema can...

10/18/2019

The Dermatologist

Managed Care Q&A

A Nuanced Approach Is Needed to Determine Value of Drugs

10/13/2018

Kara Rosania , MS;

An interview with Robert W DuBois, MD, PhD

An interview with Robert W...

10/13/2018

First Report Managed Care

Formulary Frontlines®

Immunotherapies for Melanoma: Worth the Cost?

08/15/2016

Kara Rosania , MS;

Ann W. Latner , JD;

Although melanoma, an aggressive malignant cancer of melanocytes, represents less than 5% of skin cancers, it accounts for approximately 75% of skin cancer-related deaths, according to the American Cancer Society.

Although melanoma, an aggressive...

08/15/2016

First Report Managed Care

Formulary Frontlines®

Management of Rheumatoid Arthritis

10/13/2018

Kara Rosania , MS;

Costs attributable to RA are expected to further increase as the population ages and the prevalence of obesity and physical inactivity increases.

Costs attributable to RA are...

10/13/2018

First Report Managed Care

Formulary Frontlines®

Adapting to a Changing Landscape of Rheumatoid Arthritis Therapies

03/20/2019

Kara Rosania , MS;

Rheumatoid arthritis (RA) continues to affect as many as 1.5 million adults in the United States.

Rheumatoid arthritis (RA)...

03/20/2019

First Report Managed Care

Literature Review

Improved Therapy Options for Patients with Neuroendocrine Tumors

02/23/2019

Kara Rosania , MS;

Neuroendocrine tumors (NETs) are thought to arise from cells throughout the diffuse endocrine system. According to a report published in JAMA Oncology, the incidence and prevalence of NETS are steadily rising, though for reasons not well...

Neuroendocrine tumors (NETs) are...

02/23/2019

First Report Managed Care